The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 955.00
Bid: 960.00
Ask: 963.00
Change: -28.00 (-2.85%)
Spread: 3.00 (0.313%)
Open: 987.00
High: 990.00
Low: 938.00
Prev. Close: 983.00
CVSG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

22 Jun 2023 07:00

RNS Number : 4804D
CVS Group plc
22 June 2023
 

For Immediate Release

22 June 2023

 

CVS Group plc("CVS", the "Company" or the "Group")

Appointments of non-executive director and Deputy CEO

CVS, the quoted provider of integrated veterinary services, is pleased to announce the appointment of Joanne Shaw as Non-executive Director with effect from 1 July 2023. 

 

Joanne Mary Shaw (59), has significant healthcare experience from her current roles as Trustee and Audit Committee Chair at Cancer Research UK, Chair at the Royal College of Paediatrics and Child Health, and Deputy Chair at Vitality UK. She has held a number of previous non-executive roles over the past 17 years including as non-executive director and Chair of the Audit and Risk Committee at NHS England and the National Audit Office, Chair of NHS Direct, Non-executive Director at Kensington and Chelsea Primary Care Trust and Chair of the British Equestrian Association. Joanne, who qualified as a chartered accountant, was a former management consultant at Boston Consulting Group and has previous executive roles at the Medicines Partnership, the Audit Commission and Coopers & Lybrand.

 

In her role of Non-executive Director, Joanne will become a member of the Audit, Remuneration and Nominations committees of the Board.

 

The Board is also pleased to announce the appointment of Ben Jacklin, Chief Operating Officer, to a newly created role of Deputy CEO, also with effect from 1 July 2023. Ben will retain responsibility for leading the Group's operations in the UK and internationally.

 

Chairman Richard Connell commented:

 

"On behalf of the Board I am delighted to welcome Joanne Shaw as a Non-executive Director. Her extensive healthcare experience will support the Board and the wider Group in delivering its purpose to provide the best possible care to animals. The Board looks forward to her input and to working together to deliver further success for the Group.

 

I am also delighted to congratulate Ben Jacklin on his promotion to Deputy CEO which is a reflection of Ben's significant contribution to the Group over the past few years."

 

 

Contacts:

 

CVS Group plc via Camarco

Richard Fairman, CEO

Ben Jacklin, COO

Robin Alfonso, CFO

 

Peel Hunt LLP (Nominated Adviser & Broker) +44 (0)20 7418 8900

Adrian Trimmings / Michael Burke / Andrew Clark / Lalit Bose

 

Berenberg (Joint Broker) +44 (0)20 3207 7800

Toby Flaux / Ben Wright / James Thompson / Milo Bonser

 

Camarco (Financial PR)

Geoffrey Pelham-Lane +44 (0)7733 124 226

Ginny Pulbrook +44 (0)7961 315 138

Letaba Rimell +44 (0)7789 151 644

 

 

 

Additional Disclosures under the AIM Rules for Companies:

 

In relation to the appointment of Joanne Shaw, aged 59:

 

Current directorships/partnerships Past directorships/partnerships

Royal College of Paediatrics & Child Health NHS England

Cancer Research UK Nuffield Health

Cancer Research UK Trading Ltd Discovery Holdings Europe Ltd

Imperial Cancer Research Fund

Vitality Corporate Services Ltd

Vitality Health Ltd

Vanguard Metropolitan Ltd

 

At the date of this announcement Joanne Shaw does not hold any ordinary shares in the Company.

 

Save for the above, there are no further disclosures to be made in accordance with Rule 17 and 2 paragraph (g) of the AIM Rules for Companies.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUAVAROWUNUAR
Date   Source Headline
2nd Jul 20195:32 pmRNSHolding(s) in Company
1st Jul 20195:55 pmRNSExercise of Options and Total Voting Rights
28th Jun 20197:00 amRNSTrading Update
24th Jun 20197:00 amRNSBlock listing Interim Review
6th Jun 20194:29 pmRNSHolding(s) in Company
3rd Jun 20193:32 pmRNSHolding(s) in Company
31st May 20193:11 pmRNSExercise of Options and Total Voting Rights
31st May 20193:07 pmRNSHolding(s) in Company
24th May 20195:02 pmRNSHolding(s) in Company
22nd May 20199:49 amRNSHolding(s) in Company
21st May 20199:15 amRNSHolding(s) in Company
20th May 201911:17 amRNSHolding(s) in Company
15th May 20194:09 pmRNSHolding(s) in Company
15th May 20194:09 pmRNSHolding(s) in Company
14th May 201911:28 amRNSHolding(s) in Company
9th May 201910:29 amRNSHolding(s) in Company
7th May 20192:30 pmRNSHolding(s) in Company
1st May 20197:00 amRNSTotal Voting Rights
18th Apr 20194:25 pmRNSHolding(s) in Company
18th Apr 201910:50 amRNSHolding(s) in Company
18th Apr 201910:26 amRNSHolding(s) in Company
16th Apr 20196:05 pmRNSHolding(s) in Company
10th Apr 20195:17 pmRNSHolding(s) in Company
2nd Apr 20199:42 amRNSHolding(s) in Company
29th Mar 20197:00 amRNSInterim Results
26th Mar 20194:14 pmRNSHolding(s) in Company
25th Mar 20196:21 pmRNSHolding(s) in Company
25th Mar 20191:30 pmRNSHolding(s) in Company
1st Mar 20197:00 amRNSTotal Voting Rights
15th Feb 20194:46 pmRNSHolding(s) in Company
15th Feb 20194:45 pmRNSHolding(s) in Company
15th Feb 20194:44 pmRNSHolding(s) in Company
5th Feb 20194:20 pmRNSHolding(s) in Company
5th Feb 20194:20 pmRNSHolding(s) in Company
5th Feb 20194:00 pmRNSHolding(s) in Company
4th Feb 20194:15 pmRNSHolding(s) in Company
1st Feb 20197:00 amRNSTotal Voting Rights
31st Jan 20194:41 pmRNSDirector/PDMR and PCA Shareholding
31st Jan 20198:30 amRNSDirector/PDMR Shareholding
29th Jan 20197:00 amRNSTrading Update
10th Jan 20191:51 pmRNSHolding(s) in Company
19th Dec 20187:00 amRNSBlock Admission
18th Dec 20184:45 pmRNSHolding(s) in Company
14th Dec 20187:00 amRNSExercise of Options and Total Voting Rights
6th Dec 201811:41 amRNSDirector/PDMR and PCA Shareholding
4th Dec 20186:15 pmRNSDirector/PDMR and PCA Shareholding
4th Dec 20189:47 amRNSHolding(s) in Company
3rd Dec 20184:41 pmRNSHolding(s) in Company
3rd Dec 201810:30 amRNSGrant of Options under SAYE Option Scheme and TVR
3rd Dec 201810:06 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.